Xilio Therapeutics, Inc. (XLO)
8.38
-0.08
(-0.95%)
USD |
NASDAQ |
Apr 14, 15:42
Xilio Therapeutics Cash from Investing (TTM) : -0.518M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Johnson & Johnson | -23.59B |
| Merck & Co., Inc. | -13.74B |
| Pfizer Inc. | -1.351B |
| Verastem, Inc. | -9.624M |
| Sensei Biotherapeutics, Inc. | 14.54M |